David Burkhart
11Patents
1h-index
26Co-inventors
50Inventor score
Filing activity: Oct 30, 2006 → Feb 9, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10646566B2 | Compositions and uses | Human Necessities | 1 | Active |
| US8404650B2 | Methods of treating cancer with doxazolidine and prodrugs thereof | Human Necessities | 1 | Active |
| US9827260B2 | Composition for buffered aminoalkyl glucosaminide phosphate compounds and its use for enhancing an immune response | Human Necessities | 0 | Active |
| US11912736B2 | Diaryl trehalose compounds and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11207404B2 | Compositions and uses | Human Necessities | 0 | Active |
| US11572381B2 | Immunogenic trehalose compounds and uses thereof | Human Necessities | 0 | Active |
| US12319709B2 | Diaryl trehalose compounds and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11464854B2 | Methods and compositions relating to adjuvants | Human Necessities | 0 | Active |
| US11964014B2 | Vaccine adjuvants based on TLR receptor ligands | Chemistry; Metallurgy | 0 | Active |
| US11274115B2 | Imidazoquinoline derivatives and their use in therapy | Chemistry; Metallurgy | 0 | Active |
| US12023384B2 | Immunogenic peptides comprising an MHC class II T cell epitope and a redox motif | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.